Biomarker ID | 1056 |
PMID | 23358719 |
Year | 2013 |
Biomarker | Circulating Tumor Cells (CTC) |
Biomarker Basis | CTC count |
Biomolecule | Others |
Source | Blood |
Subjects | Humans |
Regulation | Upregulated in patients with Lower Overall Survival (CTC count >=3) |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Overall Survival |
Type of Biomarker | Prognostic |
Cohort | 15 healthy controls, 20 patients with Locally advanced Prostate Cancer (LaPC), metastatic castration resistant (mCRPC, n = 40) and taxane-refractory (mTRPC, n = 15) PC patients were selected |
Senstivity | 87% |
Specificity | 67% |
AUC | 0.78 (95% CI: 0.6-0.9) |
Accuracy | NA |
Level Of Significance | p = 0.001 |
Method Used | NA |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | NA |